Study showed that miR-29c efficiently downregulated B7-H3 expression and the expression of miR-29c correlated with survival rate of breast cancer patients, suggesting a tumor suppressive role of miR-29c [35]. This evidence concerns the gene CD276 and breast carcinoma.